<DOC>
	<DOCNO>NCT00954291</DOCNO>
	<brief_summary>The objective study characterize pharmacokinetic profile granisetron patch single administration healthy subject .</brief_summary>
	<brief_title>An Open-label , Single Dose Pharmacokinetic Study 14 mg Granisetron Patch Healthy Subjects</brief_title>
	<detailed_description>The objective study characterize pharmacokinetic profile granisetron patch single administration healthy subject .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<criteria>1 . Subjects must male age 2040 year old good health basis medical history , physical examination , electrocardiogram , chest Xray , routine laboratory evaluation . 2 . Vital sign ( 3 minute rest upright position ) within follow range : Ear body temperature 35.037.5 Â°C.Systolic blood pressure , 90140 mm Hg.Diastolic blood pressure , 5090 mm Hg.Pulse rate , 5090 bpm.Fasting blood glucose , &lt; 100 mg/dL . 3 . Body weight must 50 kg within 20 +20 % ideal body weight . 4 . Able sign inform consent prior study . 5 . Able communicate well investigator comply requirement study . 1 . Use prescription medication within 14 day prior dose . 2 . Use overthecounter medication vitamin within 14 day prior dose . 3 . Significant illness within 2 week prior dose . 4 . Participation clinical investigation within 2 month prior dose longer required local regulation . 5 . Donate loss 500 mL blood within 3 month prior dose . 6 . Presence cardiovascular disease . 7 . Presence gastrointestinal disease . 8 . Presence asthma lung disease . 9 . Presence liver disease , hepatitis B , hepatitis C liver injury indicate abnormal liver function profile GOT , GPT , gGT , alkaline phosphatase , serum bilirubin , HBsAg , AntiHCV . 10 . Presence impair renal function indicate abnormal creatinine BUN value abnormal urinary constituent ( e.g. , albuminuria ) . 11 . Presence neurological disease . 12 . Presence psychiatrical disease . 13 . Subject know HIV infect . 14 . A known hypersensitivity granisetron analog . 15 . History drug alcohol abuse within 12 month prior dose . 16 . Permanent confinement institution . 17 . Individuals judge investigator pharmacokineticist undesirable subject reason .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>antinauseant antiemetic</keyword>
</DOC>